|
REDCROSS REQUEST
The
American National Red Cross (Red Cross) Jerome
H. Holland Laboratory for Biomedical Research in
Rockville,
Maryland is collecting small
volumes of blood from patients afflicted with
various forms of transmissible spongiform
encephalopathies (TSE)/prion diseases and their
blood-related family members. The purpose of the
research is to build a blood sample repository
for studies on ways to detect the presence of
prion protein or other markers of the disease in
human blood.
Recent epidemiological
evidence indicates that blood of patients with
variant form of Creutzfeldt-Jakob disease
(vCJD), that is prevalent in the United Kingdom, is infectious.
The questions about the
possibility that blood from patients with the
sporadic and familial forms of TSE might also be
infectious is still not resolved even though 10
years of searching has not revealed any examples
of blood-related transmission from patients with
these non-variant forms of disease.
The development of a blood
test to identify affected people in the
pre-clinical stage of disease could eliminate
the uncertainty about TSE-related blood safety.
Some tests have been successful for
testing animals infected with TSEs, but in order
to know if any test will be reliable in humans,
we need to test human blood.
CJD patients and their
families are the only source of blood specimens
that can answer this question, and we therefore
ask you to support our effort.
If you or an affected relative
is interested in participating, please contact
the name listed below. No more than 50 ml of
blood should be collected at a location
convenient to you through your own arrangements
with your physician and the blood sample should
be sent to the Holland Laboratory at no cost to
you. The samples will be processed and stored,
frozen indefinitely, at the Holland Laboratory
in
Rockville, Maryland. The Red Cross will provide access
to only designated research staff at the Red
Cross or other research groups that have
provided convincing evidence for a test to
detect TSE in animals.
Participating individuals will
NOT be notified about test results because the
tests that will be performed on blood are
experimental and their significance is not known
and will remain uncertain for some years to
come. The CJD foundation will be notified of any
publications coming from our research.
Contact information:
Dr. Larisa Cervenakova; Phone: 301-738-0765;
e-mail:
cervenakl@usa.redcross.org
|